UY27959A1 - Nuevos agonistas ppar alfa y ppar gama - Google Patents
Nuevos agonistas ppar alfa y ppar gamaInfo
- Publication number
- UY27959A1 UY27959A1 UY27959A UY27959A UY27959A1 UY 27959 A1 UY27959 A1 UY 27959A1 UY 27959 A UY27959 A UY 27959A UY 27959 A UY27959 A UY 27959A UY 27959 A1 UY27959 A1 UY 27959A1
- Authority
- UY
- Uruguay
- Prior art keywords
- ppar
- agarist
- new
- range
- alfa
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pregnancy & Childbirth (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se refiere a compuestos de fórmula (I) en donde R1 a R10, X, Y y n son tal como se han definido en la descripción y las reivindicaciones, y las sales y ésteres farmacéuticamente aceptables de los mismos. Los compuestos son útiles para el tratamiento de enfermedades tales como la diabetes.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02019146 | 2002-08-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY27959A1 true UY27959A1 (es) | 2004-02-27 |
Family
ID=31970267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY27959A UY27959A1 (es) | 2002-08-30 | 2003-08-27 | Nuevos agonistas ppar alfa y ppar gama |
Country Status (30)
Country | Link |
---|---|
US (1) | US6809110B2 (es) |
EP (1) | EP1537091B1 (es) |
JP (2) | JP4533141B2 (es) |
KR (1) | KR100736955B1 (es) |
CN (1) | CN100475810C (es) |
AR (1) | AR041079A1 (es) |
AT (1) | ATE483699T1 (es) |
BR (1) | BR0313946A (es) |
CA (1) | CA2495942C (es) |
DE (1) | DE60334461D1 (es) |
DK (1) | DK1537091T3 (es) |
ES (1) | ES2350340T3 (es) |
GT (1) | GT200300183A (es) |
HK (1) | HK1082504A1 (es) |
HR (1) | HRP20050158A2 (es) |
IL (1) | IL166833A (es) |
MX (1) | MXPA05002115A (es) |
MY (1) | MY141020A (es) |
NO (1) | NO329777B1 (es) |
NZ (1) | NZ537897A (es) |
PA (1) | PA8581201A1 (es) |
PE (1) | PE20040982A1 (es) |
PL (1) | PL375779A1 (es) |
PT (1) | PT1537091E (es) |
RU (1) | RU2296754C2 (es) |
SI (1) | SI1537091T1 (es) |
TW (1) | TWI338686B (es) |
UY (1) | UY27959A1 (es) |
WO (1) | WO2004020420A1 (es) |
ZA (1) | ZA200501097B (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7105551B2 (en) * | 2000-12-20 | 2006-09-12 | Smithkline Beecham Corporation | Thiazole derivatives for treating PPAR related disorders |
CA2495942C (en) * | 2002-08-30 | 2010-03-23 | F. Hoffmann-La Roche Ag | Novel 2-arylthiazole compounds as pparalpha and ppargamma agonists |
GB0405033D0 (en) * | 2004-03-05 | 2004-04-07 | Karobio Ab | Novel pharmaceutical compositions |
JP2009084156A (ja) * | 2006-01-18 | 2009-04-23 | Nissan Chem Ind Ltd | チアゾール置換アセトニトリルの製造方法 |
US20100063041A1 (en) * | 2007-03-07 | 2010-03-11 | Ho-Sang Moon | Novel phenylpropionic acid derivatives as peroxisome proliferator-activated gamma receptor modulators, method of the same, and pharmaceutical composition comprising the same |
WO2008108602A1 (en) * | 2007-03-07 | 2008-09-12 | Dong-A Pharm. Co., Ltd. | Novel phenylpropionic acid derivatives as peroxisome proliferator-activated gamma receptor modulators, method of the same, and pharmaceutical composition comprising the same |
DE102007038251A1 (de) * | 2007-08-13 | 2009-02-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neues Herstellverfahren |
CN101928259B (zh) * | 2009-06-18 | 2012-10-03 | 南京海辰药业有限公司 | 2-芳基噻唑衍生物及其药物组合物 |
CN102285933B (zh) * | 2010-06-18 | 2016-03-09 | 浙江海正药业股份有限公司 | 一种对亚型过氧化物酶增殖物激活受体具有激动作用的化合物、其制备方法和应用 |
CN102351852B (zh) * | 2011-08-23 | 2014-06-18 | 上海交通大学 | 苯并呋喃类化合物及其制备方法、用途 |
EP2758041B1 (de) | 2011-09-20 | 2021-01-13 | Basf Se | Niedermolekulare modulatoren des kälte-menthol-rezeptors trpm8 und deren verwendung |
EP3478297A1 (en) | 2016-06-30 | 2019-05-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of cardiomyopathies |
EP3595777A4 (en) * | 2017-03-14 | 2021-01-20 | Dana-Farber Cancer Institute, Inc. | SENSITIZATION OF SMALL MOLECULES TO BAX ACTIVATION FOR INDUCTION OF CELLULAR DEATH |
WO2020201263A1 (en) | 2019-04-01 | 2020-10-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment and prevention of cardiac remodeling |
CN115894379A (zh) * | 2022-01-20 | 2023-04-04 | 中国药科大学 | 海因类化合物及其医药用途 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4011326A (en) * | 1975-07-29 | 1977-03-08 | Merck & Co., Inc. | 2-Substituted oxazolo[4,5-b]pyridine anti-inflammatory agents |
US5089514A (en) * | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
PL176885B1 (pl) * | 1992-07-03 | 1999-08-31 | Smithkline Beecham Plc | Kompozycja farmaceutyczna |
GB9225386D0 (en) | 1992-12-04 | 1993-01-27 | Smithkline Beecham Plc | Novel compounds |
DE4317320A1 (de) * | 1993-05-25 | 1994-12-01 | Boehringer Mannheim Gmbh | Neue Thiazolidindione und diese enthaltende Arzneimittel |
GB9326171D0 (en) | 1993-12-22 | 1994-02-23 | Smithkline Beecham Plc | Novel compounds |
GB9600464D0 (en) | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
WO1998025606A1 (en) * | 1996-12-10 | 1998-06-18 | Bristol-Myers Squibb Company | Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agents |
DE19711616A1 (de) * | 1997-03-20 | 1998-09-24 | Boehringer Mannheim Gmbh | Verbessertes Verfahren zur Herstellung von Thiazolidindionen |
US6121397A (en) * | 1997-07-14 | 2000-09-19 | Xerox Corporation | Polymerization processes using oligomeric compound, monomer and surfactant |
HN1998000118A (es) | 1997-08-27 | 1999-02-09 | Pfizer Prod Inc | 2 - aminopiridinas que contienen sustituyentes de anillos condensados. |
EP0903343B1 (en) | 1997-09-19 | 2003-05-28 | SSP Co., Ltd. | Alpha-Substituted phenylpropionic acid derivative and medicine containing the same |
DE69828445D1 (de) | 1998-04-23 | 2005-02-03 | Reddys Lab Ltd Dr | Heterozyklische verbindungen,und deren verwendung in arzneimittel,verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen |
GB9817118D0 (en) * | 1998-08-07 | 1998-10-07 | Glaxo Group Ltd | Pharmaceutical compounds |
GB9914977D0 (en) * | 1999-06-25 | 1999-08-25 | Glaxo Group Ltd | Chemical compounds |
ES2258431T3 (es) * | 1999-08-02 | 2006-09-01 | F. Hoffmann-La Roche Ag | Proceso para la preparacion de derivados de benzotiofeno. |
JP2001261612A (ja) * | 2000-03-22 | 2001-09-26 | Mitsui Chemicals Inc | カテコールプロピオン酸誘導体およびそれを有効成分として含有する核内レセプター作動薬 |
CA2418104A1 (en) * | 2000-08-23 | 2002-02-28 | Eli Lilly And Company | Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists |
SI1392295T1 (sl) * | 2001-05-15 | 2006-10-31 | Hoffmann La Roche | Derivati oksazola, substituirani s karboksilno kislino, za uporabo kot ppar -alfa in -gama aktivatorji pri zdravljenju diabetesa |
ATE415160T1 (de) * | 2002-02-25 | 2008-12-15 | Lilly Co Eli | Modulatoren von peroxisome proliferator- aktivierten rezeptoren |
CA2495942C (en) * | 2002-08-30 | 2010-03-23 | F. Hoffmann-La Roche Ag | Novel 2-arylthiazole compounds as pparalpha and ppargamma agonists |
-
2003
- 2003-08-21 CA CA2495942A patent/CA2495942C/en not_active Expired - Fee Related
- 2003-08-21 DK DK03757762.4T patent/DK1537091T3/da active
- 2003-08-21 PL PL03375779A patent/PL375779A1/xx not_active Application Discontinuation
- 2003-08-21 SI SI200331904T patent/SI1537091T1/sl unknown
- 2003-08-21 KR KR1020057003571A patent/KR100736955B1/ko not_active IP Right Cessation
- 2003-08-21 ES ES03757762T patent/ES2350340T3/es not_active Expired - Lifetime
- 2003-08-21 DE DE60334461T patent/DE60334461D1/de not_active Expired - Lifetime
- 2003-08-21 PT PT03757762T patent/PT1537091E/pt unknown
- 2003-08-21 WO PCT/EP2003/009281 patent/WO2004020420A1/en active IP Right Grant
- 2003-08-21 MX MXPA05002115A patent/MXPA05002115A/es active IP Right Grant
- 2003-08-21 NZ NZ537897A patent/NZ537897A/en not_active IP Right Cessation
- 2003-08-21 AT AT03757762T patent/ATE483699T1/de active
- 2003-08-21 EP EP03757762A patent/EP1537091B1/en not_active Expired - Lifetime
- 2003-08-21 CN CNB038205432A patent/CN100475810C/zh not_active Expired - Fee Related
- 2003-08-21 BR BR0313946-8A patent/BR0313946A/pt not_active IP Right Cessation
- 2003-08-21 JP JP2004532104A patent/JP4533141B2/ja not_active Expired - Fee Related
- 2003-08-21 RU RU2005109163/04A patent/RU2296754C2/ru not_active IP Right Cessation
- 2003-08-26 TW TW092123445A patent/TWI338686B/zh not_active IP Right Cessation
- 2003-08-26 PE PE2003000873A patent/PE20040982A1/es not_active Application Discontinuation
- 2003-08-26 PA PA20038581201A patent/PA8581201A1/es unknown
- 2003-08-27 GT GT200300183A patent/GT200300183A/es unknown
- 2003-08-27 UY UY27959A patent/UY27959A1/es not_active Application Discontinuation
- 2003-08-28 MY MYPI20033266A patent/MY141020A/en unknown
- 2003-08-28 AR ARP030103120A patent/AR041079A1/es active IP Right Grant
- 2003-08-28 US US10/650,434 patent/US6809110B2/en not_active Expired - Fee Related
-
2005
- 2005-02-03 NO NO20050620A patent/NO329777B1/no not_active IP Right Cessation
- 2005-02-07 ZA ZA200501097A patent/ZA200501097B/en unknown
- 2005-02-10 IL IL166833A patent/IL166833A/en not_active IP Right Cessation
- 2005-02-18 HR HR20050158A patent/HRP20050158A2/xx not_active Application Discontinuation
-
2006
- 2006-04-03 HK HK06104073.6A patent/HK1082504A1/xx not_active IP Right Cessation
-
2010
- 2010-01-14 JP JP2010006072A patent/JP2010132671A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8544901A1 (es) | Derivados de oxazol | |
UY27959A1 (es) | Nuevos agonistas ppar alfa y ppar gama | |
CR9980A (es) | Imidazolinas 4,4,5,5 tetrasustituidas | |
UY27666A1 (es) | Nuevos derivados de piridina y quinolina | |
UY27665A1 (es) | Nuevos derivados de piridina y pirimidina | |
UY27518A1 (es) | Nuevos derivados de pirrolidina | |
ECSP056240A (es) | Derivados de pirido[2,1-a]isoquinolina como inhibidores de dpp-iv | |
UY27918A1 (es) | Derivados de benzodioxol | |
ECSP055633A (es) | Nuevos derivados de benzoimidazolutiles como angentes antiproliferativos | |
PA8562801A1 (es) | Nuevos derivados de pirido (2,1-a) isoquinolina | |
UY29636A1 (es) | 2,4-diamino-pirimidinas como inhibidores de aurora | |
CR8744A (es) | Compuestos terapeuticos | |
CR10233A (es) | Piridin-4-ilmetilamidas | |
UY27705A1 (es) | Compuestos quimicos. | |
UY27872A1 (es) | Inhibidores de caspasa y usos de los mismos. | |
CO5640114A2 (es) | 4-(2,4-dicloro-5-metoxifenil)amino -6-alcoxi-3-quinolincarbonitrilos para el tratamiento de lesiones isquemicas | |
GEP201606545B (en) | 2-piperazin-1-yl-4h-1,3-benzo-thiazin-4-one derivatives and their use for treatment of mammalian infections | |
UY26847A1 (es) | Derivados de la pirrolidina | |
UY28006A1 (es) | Agonistas ppar quirales | |
UY27975A1 (es) | Derivados de indolilo | |
NI201000065A (es) | CARBONO UNIDO A LOS MODULADORES DE LA y-SECRETASA. | |
NI201000063A (es) | AMINAS UNIDAS A LOS MODULADORES DE LA y-SECRETASA. | |
ECSP088153A (es) | Nuevos derivados de piperidina | |
UY26846A1 (es) | Derivados de la pirrolidina | |
UY32002A (es) | Piridinilo moduladores de gamma-secretasa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20150126 |